» Articles » PMID: 35789843

A Systematic Characterization of Microglia-like Cell Occurrence During Retinal Organoid Differentiation

Overview
Journal iScience
Publisher Cell Press
Date 2022 Jul 5
PMID 35789843
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral organoids differentiated from human-induced pluripotent stem cells (hiPSC) provide a unique opportunity to investigate brain development. However, organoids usually lack microglia, brain-resident immune cells, which are present in the early embryonic brain and participate in neuronal circuit development. Here, we find IBA1 microglia-like cells alongside retinal cups between week 3 and 4 in 2.5D culture with an unguided retinal organoid differentiation protocol. Microglia do not infiltrate the neuroectoderm and instead enrich within non-pigmented, 3D-cystic compartments that develop in parallel to the 3D-retinal organoids. When we guide the retinal organoid differentiation with low-dosed BMP4, we prevent cup development and enhance microglia and 3D-cysts formation. Mass spectrometry identifies these 3D-cysts to express mesenchymal and epithelial markers. We confirmed this microglia-preferred environment also within the unguided protocol, providing insight into microglial behavior and migration and offer a model to study how they enter and distribute within the human brain.

Citing Articles

Advances in physiological and clinical relevance of hiPSC-derived brain models for precision medicine pipelines.

Imani Farahani N, Lin L, Nazir S, Naderi A, Rokos L, McIntosh A Front Cell Neurosci. 2025; 18():1478572.

PMID: 39835290 PMC: 11743572. DOI: 10.3389/fncel.2024.1478572.


Induced pluripotent stem cell-derived macrophages as a platform for modelling human disease.

Tiwari S, Wong W, Moreira M, Pasqualini C, Ginhoux F Nat Rev Immunol. 2024; 25(2):108-124.

PMID: 39333753 DOI: 10.1038/s41577-024-01081-x.


Emerging Models to Study Human Microglia In vitro.

Jantti H, Kistemaker L, Buonfiglioli A, de Witte L, Malm T, Hol E Adv Neurobiol. 2024; 37:545-568.

PMID: 39207712 DOI: 10.1007/978-3-031-55529-9_30.


Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke.

Zhang Y, Li J, Zhao Y, Huang Y, Shi Z, Wang H Sci Adv. 2024; 10(10):eade6900.

PMID: 38446877 PMC: 10917353. DOI: 10.1126/sciadv.ade6900.


Microglial morphometric analysis: so many options, so little consistency.

Reddaway J, Richardson P, Bevan R, Stoneman J, Palombo M Front Neuroinform. 2023; 17:1211188.

PMID: 37637472 PMC: 10448193. DOI: 10.3389/fninf.2023.1211188.


References
1.
Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S . Common genetic variation drives molecular heterogeneity in human iPSCs. Nature. 2017; 546(7658):370-375. PMC: 5524171. DOI: 10.1038/nature22403. View

2.
Guttikonda S, Sikkema L, Tchieu J, Saurat N, Walsh R, Harschnitz O . Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer's disease. Nat Neurosci. 2021; 24(3):343-354. PMC: 8382543. DOI: 10.1038/s41593-020-00796-z. View

3.
McQuade A, Coburn M, Tu C, Hasselmann J, Davtyan H, Blurton-Jones M . Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol Neurodegener. 2018; 13(1):67. PMC: 6303871. DOI: 10.1186/s13024-018-0297-x. View

4.
Satoh J, Kino Y, Asahina N, Takitani M, Miyoshi J, Ishida T . TMEM119 marks a subset of microglia in the human brain. Neuropathology. 2015; 36(1):39-49. DOI: 10.1111/neup.12235. View

5.
Zhang P, Li J, Tan Z, Wang C, Liu T, Chen L . Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood. 2007; 111(4):1933-41. DOI: 10.1182/blood-2007-02-074120. View